Exigyn’s Post

“A pharma company stopped using Microsoft's Copilot AI tool, with an exec citing high cost and low value.” “He compared the slide-generation capability of Microsoft's AI tools to middle school presentations, according to a transcript of a call with the Morgan Stanley analysts that was included in their research note.” “The chief information officer of a pharma company paid extra to have 500 employees use Office 365 Copilot in the fourth quarter of 2023 and first quarter of 2024. This is Microsoft's much-heralded AI upgrade to its popular suite of productivity software.” He paid “about $34 per user a month” for the “E3 version of Microsoft's 365 software suite.” “Adding Copilot AI features costs another $30 per user a month. For 500 employees, that would roughly add an extra $180,000 a year.” “These new Microsoft tools are considered some of the premier examples of powerful artificial intelligence in action in the real world. Investors have bid up Microsoft and other big #tech shares massively, betting that this product and similar offerings will catch on with paying customers.” But the article says: “If a large pharma company can't see $180,000 of value in these tools, that's a problem that should worry the entire tech industry,” a worry that I have written about many times. I have trouble finding any examples of companies claiming productivity improvements from generative text AI, and only a few for generative video AI (marketing videos and helping with movie and TV shows). There was one AI feature that the IT executive found somewhat compelling: that “was the ability to archive and summarize video meetings on Microsoft's Teams app. But he said his legal team was wary of retaining meeting transcripts, so the pharma company didn't use that feature.” Other people have shared their concerns with me about the legal problems from storing their proprietary information like this. Investors are also concerned and thus there are many comments, both internal and external to Microsoft, about “whether its AI services will create enough value to persuade corporate customers to pay more.” “The company is amassing 1.8 million graphics processing units to build and run AI models and related products. It also has a plan to triple data-center capacity, mainly to handle AI workloads. Its capital expenditure hit a record $14 billion in the most recent quarter.” Many investors are concerned that this pharma company isn’t the only company that is finding Microsoft’s Copilot AI services, and those from other companies, not as beneficial as many proclaim. With a big runup in the market capitalizations of the big tech companies over the last 18 months, particularly of the so-called Magnificent 7, those concerns could spark a move in the opposite direction for the share prices of the Magnificent 7.   #technology #innovation #startups #ethics #artificialintelligence https://lnkd.in/gJ_FHBAB

“A pharma company stopped using Microsoft's Copilot AI tool, with an exec citing high cost and low value.” “He compared the slide-generation capability of Microsoft's AI tools to middle school presentations, according to a transcript of a call with the Morgan Stanley analysts that was included in their research note.” “The chief information officer of a pharma company paid extra to have 500 employees use Office 365 Copilot in the fourth quarter of 2023 and first quarter of 2024. This is Microsoft's much-heralded AI upgrade to its popular suite of productivity software.” He paid “about $34 per user a month” for the “E3 version of Microsoft's 365 software suite.” “Adding Copilot AI features costs another $30 per user a month. For 500 employees, that would roughly add an extra $180,000 a year.” “These new Microsoft tools are considered some of the premier examples of powerful artificial intelligence in action in the real world. Investors have bid up Microsoft and other big #tech shares massively, betting that this product and similar offerings will catch on with paying customers.” But the article says: “If a large pharma company can't see $180,000 of value in these tools, that's a problem that should worry the entire tech industry,” a worry that I have written about many times. I have trouble finding any examples of companies claiming productivity improvements from generative text AI, and only a few for generative video AI (marketing videos and helping with movie and TV shows). There was one AI feature that the IT executive found somewhat compelling: that “was the ability to archive and summarize video meetings on Microsoft's Teams app. But he said his legal team was wary of retaining meeting transcripts, so the pharma company didn't use that feature.” Other people have shared their concerns with me about the legal problems from storing their proprietary information like this. Investors are also concerned and thus there are many comments, both internal and external to Microsoft, about “whether its AI services will create enough value to persuade corporate customers to pay more.” “The company is amassing 1.8 million graphics processing units to build and run AI models and related products. It also has a plan to triple data-center capacity, mainly to handle AI workloads. Its capital expenditure hit a record $14 billion in the most recent quarter.” Many investors are concerned that this pharma company isn’t the only company that is finding Microsoft’s Copilot AI services, and those from other companies, not as beneficial as many proclaim. With a big runup in the market capitalizations of the big tech companies over the last 18 months, particularly of the so-called Magnificent 7, those concerns could spark a move in the opposite direction for the share prices of the Magnificent 7.   #technology #innovation #startups #ethics #artificialintelligence https://lnkd.in/gJ_FHBAB

“A pharma company stopped using Microsoft's Copilot AI tool, with an exec citing high cost and low value.” “He compared the slide-generation capability of Microsoft's AI tools to middle school presentations, according to a transcript of a call with the Morgan Stanley analysts that was included in their research note.” “The chief information officer of a pharma company paid extra to have 500 employees use Office 365 Copilot in the fourth quarter of 2023 and first quarter of 2024. This is Microsoft's much-heralded AI upgrade to its popular suite of productivity software.” He paid “about $34 per user a month” for the “E3 version of Microsoft's 365 software suite.” “Adding Copilot AI features costs another $30 per user a month. For 500 employees, that would roughly add an extra $180,000 a year.” “These new Microsoft tools are considered some of the premier examples of powerful artificial intelligence in action in the real world. Investors have bid up Microsoft and other big #tech shares massively, betting that this product and similar offerings will catch on with paying customers.” But the article says: “If a large pharma company can't see $180,000 of value in these tools, that's a problem that should worry the entire tech industry,” a worry that I have written about many times. I have trouble finding any examples of companies claiming productivity improvements from generative text AI, and only a few for generative video AI (marketing videos and helping with movie and TV shows). There was one AI feature that the IT executive found somewhat compelling: that “was the ability to archive and summarize video meetings on Microsoft's Teams app. But he said his legal team was wary of retaining meeting transcripts, so the pharma company didn't use that feature.” Other people have shared their concerns with me about the legal problems from storing their proprietary information like this. Investors are also concerned and thus there are many comments, both internal and external to Microsoft, about “whether its AI services will create enough value to persuade corporate customers to pay more.” “The company is amassing 1.8 million graphics processing units to build and run AI models and related products. It also has a plan to triple data-center capacity, mainly to handle AI workloads. Its capital expenditure hit a record $14 billion in the most recent quarter.” Many investors are concerned that this pharma company isn’t the only company that is finding Microsoft’s Copilot AI services, and those from other companies, not as beneficial as many proclaim. With a big runup in the market capitalizations of the big tech companies over the last 18 months, particularly of the so-called Magnificent 7, those concerns could spark a move in the opposite direction for the share prices of the Magnificent 7.   #technology #innovation #startups #ethics #artificialintelligence https://lnkd.in/gJ_FHBAB

“A pharma company stopped using Microsoft's Copilot AI tool, with an exec citing high cost and low value.” “He compared the slide-generation capability of Microsoft's AI tools to middle school presentations, according to a transcript of a call with the Morgan Stanley analysts that was included in their research note.” “The chief information officer of a pharma company paid extra to have 500 employees use Office 365 Copilot in the fourth quarter of 2023 and first quarter of 2024. This is Microsoft's much-heralded AI upgrade to its popular suite of productivity software.” He paid “about $34 per user a month” for the “E3 version of Microsoft's 365 software suite.” “Adding Copilot AI features costs another $30 per user a month. For 500 employees, that would roughly add an extra $180,000 a year.” “These new Microsoft tools are considered some of the premier examples of powerful artificial intelligence in action in the real world. Investors have bid up Microsoft and other big #tech shares massively, betting that this product and similar offerings will catch on with paying customers.” But the article says: “If a large pharma company can't see $180,000 of value in these tools, that's a problem that should worry the entire tech industry,” a worry that I have written about many times. I have trouble finding any examples of companies claiming productivity improvements from generative text AI, and only a few for generative video AI (marketing videos and helping with movie and TV shows). There was one AI feature that the IT executive found somewhat compelling: that “was the ability to archive and summarize video meetings on Microsoft's Teams app. But he said his legal team was wary of retaining meeting transcripts, so the pharma company didn't use that feature.” Other people have shared their concerns with me about the legal problems from storing their proprietary information like this. Investors are also concerned and thus there are many comments, both internal and external to Microsoft, about “whether its AI services will create enough value to persuade corporate customers to pay more.” “The company is amassing 1.8 million graphics processing units to build and run AI models and related products. It also has a plan to triple data-center capacity, mainly to handle AI workloads. Its capital expenditure hit a record $14 billion in the most recent quarter.” Many investors are concerned that this pharma company isn’t the only company that is finding Microsoft’s Copilot AI services, and those from other companies, not as beneficial as many proclaim. With a big runup in the market capitalizations of the big tech companies over the last 18 months, particularly of the so-called Magnificent 7, those concerns could spark a move in the opposite direction for the share prices of the Magnificent 7.   #technology #innovation #startups #ethics #artificialintelligence https://lnkd.in/gJ_FHBAB

“A pharma company stopped using Microsoft's Copilot AI tool, with an exec citing high cost and low value.” “He compared the slide-generation capability of Microsoft's AI tools to middle school presentations, according to a transcript of a call with the Morgan Stanley analysts that was included in their research note.” “The chief information officer of a pharma company paid extra to have 500 employees use Office 365 Copilot in the fourth quarter of 2023 and first quarter of 2024. This is Microsoft's much-heralded AI upgrade to its popular suite of productivity software.” He paid “about $34 per user a month” for the “E3 version of Microsoft's 365 software suite.” “Adding Copilot AI features costs another $30 per user a month. For 500 employees, that would roughly add an extra $180,000 a year.” “These new Microsoft tools are considered some of the premier examples of powerful artificial intelligence in action in the real world. Investors have bid up Microsoft and other big #tech shares massively, betting that this product and similar offerings will catch on with paying customers.” But the article says: “If a large pharma company can't see $180,000 of value in these tools, that's a problem that should worry the entire tech industry,” a worry that I have written about many times. I have trouble finding any examples of companies claiming productivity improvements from generative text AI, and only a few for generative video AI (marketing videos and helping with movie and TV shows). There was one AI feature that the IT executive found somewhat compelling: that “was the ability to archive and summarize video meetings on Microsoft's Teams app. But he said his legal team was wary of retaining meeting transcripts, so the pharma company didn't use that feature.” Other people have shared their concerns with me about the legal problems from storing their proprietary information like this. Investors are also concerned and thus there are many comments, both internal and external to Microsoft, about “whether its AI services will create enough value to persuade corporate customers to pay more.” “The company is amassing 1.8 million graphics processing units to build and run AI models and related products. It also has a plan to triple data-center capacity, mainly to handle AI workloads. Its capital expenditure hit a record $14 billion in the most recent quarter.” Many investors are concerned that this pharma company isn’t the only company that is finding Microsoft’s Copilot AI services, and those from other companies, not as beneficial as many proclaim. With a big runup in the market capitalizations of the big tech companies over the last 18 months, particularly of the so-called Magnificent 7, those concerns could spark a move in the opposite direction for the share prices of the Magnificent 7.   #technology #innovation #startups #ethics #artificialintelligence https://lnkd.in/gJ_FHBAB

“A pharma company stopped using Microsoft's Copilot AI tool, with an exec citing high cost and low value.” “He compared the slide-generation capability of Microsoft's AI tools to middle school presentations, according to a transcript of a call with the Morgan Stanley analysts that was included in their research note.” “The chief information officer of a pharma company paid extra to have 500 employees use Office 365 Copilot in the fourth quarter of 2023 and first quarter of 2024. This is Microsoft's much-heralded AI upgrade to its popular suite of productivity software.” He paid “about $34 per user a month” for the “E3 version of Microsoft's 365 software suite.” “Adding Copilot AI features costs another $30 per user a month. For 500 employees, that would roughly add an extra $180,000 a year.” “These new Microsoft tools are considered some of the premier examples of powerful artificial intelligence in action in the real world. Investors have bid up Microsoft and other big #tech shares massively, betting that this product and similar offerings will catch on with paying customers.” But the article says: “If a large pharma company can't see $180,000 of value in these tools, that's a problem that should worry the entire tech industry,” a worry that I have written about many times. I have trouble finding any examples of companies claiming productivity improvements from generative text AI, and only a few for generative video AI (marketing videos and helping with movie and TV shows). There was one AI feature that the IT executive found somewhat compelling: that “was the ability to archive and summarize video meetings on Microsoft's Teams app. But he said his legal team was wary of retaining meeting transcripts, so the pharma company didn't use that feature.” Other people have shared their concerns with me about the legal problems from storing their proprietary information like this. Investors are also concerned and thus there are many comments, both internal and external to Microsoft, about “whether its AI services will create enough value to persuade corporate customers to pay more.” “The company is amassing 1.8 million graphics processing units to build and run AI models and related products. It also has a plan to triple data-center capacity, mainly to handle AI workloads. Its capital expenditure hit a record $14 billion in the most recent quarter.” Many investors are concerned that this pharma company isn’t the only company that is finding Microsoft’s Copilot AI services, and those from other companies, not as beneficial as many proclaim. With a big runup in the market capitalizations of the big tech companies over the last 18 months, particularly of the so-called Magnificent 7, those concerns could spark a move in the opposite direction for the share prices of the Magnificent 7.   #technology #innovation #startups #ethics #artificialintelligence https://lnkd.in/gJ_FHBAB

“A pharma company stopped using Microsoft's Copilot AI tool, with an exec citing high cost and low value.” “He compared the slide-generation capability of Microsoft's AI tools to middle school presentations, according to a transcript of a call with the Morgan Stanley analysts that was included in their research note.” “The chief information officer of a pharma company paid extra to have 500 employees use Office 365 Copilot in the fourth quarter of 2023 and first quarter of 2024. This is Microsoft's much-heralded AI upgrade to its popular suite of productivity software.” He paid “about $34 per user a month” for the “E3 version of Microsoft's 365 software suite.” “Adding Copilot AI features costs another $30 per user a month. For 500 employees, that would roughly add an extra $180,000 a year.” “These new Microsoft tools are considered some of the premier examples of powerful artificial intelligence in action in the real world. Investors have bid up Microsoft and other big #tech shares massively, betting that this product and similar offerings will catch on with paying customers.” But the article says: “If a large pharma company can't see $180,000 of value in these tools, that's a problem that should worry the entire tech industry,” a worry that I have written about many times. I have trouble finding any examples of companies claiming productivity improvements from generative text AI, and only a few for generative video AI (marketing videos and helping with movie and TV shows). There was one AI feature that the IT executive found somewhat compelling: that “was the ability to archive and summarize video meetings on Microsoft's Teams app. But he said his legal team was wary of retaining meeting transcripts, so the pharma company didn't use that feature.” Other people have shared their concerns with me about the legal problems from storing their proprietary information like this. Investors are also concerned and thus there are many comments, both internal and external to Microsoft, about “whether its AI services will create enough value to persuade corporate customers to pay more.” “The company is amassing 1.8 million graphics processing units to build and run AI models and related products. It also has a plan to triple data-center capacity, mainly to handle AI workloads. Its capital expenditure hit a record $14 billion in the most recent quarter.” Many investors are concerned that this pharma company isn’t the only company that is finding Microsoft’s Copilot AI services, and those from other companies, not as beneficial as many proclaim. With a big runup in the market capitalizations of the big tech companies over the last 18 months, particularly of the so-called Magnificent 7, those concerns could spark a move in the opposite direction for the share prices of the Magnificent 7.   #technology #innovation #startups #ethics #artificialintelligence https://lnkd.in/gJ_FHBAB

“A pharma company stopped using Microsoft's Copilot AI tool, with an exec citing high cost and low value.” “He compared the slide-generation capability of Microsoft's AI tools to middle school presentations, according to a transcript of a call with the Morgan Stanley analysts that was included in their research note.” “The chief information officer of a pharma company paid extra to have 500 employees use Office 365 Copilot in the fourth quarter of 2023 and first quarter of 2024. This is Microsoft's much-heralded AI upgrade to its popular suite of productivity software.” He paid “about $34 per user a month” for the “E3 version of Microsoft's 365 software suite.” “Adding Copilot AI features costs another $30 per user a month. For 500 employees, that would roughly add an extra $180,000 a year.” “These new Microsoft tools are considered some of the premier examples of powerful artificial intelligence in action in the real world. Investors have bid up Microsoft and other big #tech shares massively, betting that this product and similar offerings will catch on with paying customers.” But the article says: “If a large pharma company can't see $180,000 of value in these tools, that's a problem that should worry the entire tech industry,” a worry that I have written about many times. I have trouble finding any examples of companies claiming productivity improvements from generative text AI, and only a few for generative video AI (marketing videos and helping with movie and TV shows). There was one AI feature that the IT executive found somewhat compelling: that “was the ability to archive and summarize video meetings on Microsoft's Teams app. But he said his legal team was wary of retaining meeting transcripts, so the pharma company didn't use that feature.” Other people have shared their concerns with me about the legal problems from storing their proprietary information like this. Investors are also concerned and thus there are many comments, both internal and external to Microsoft, about “whether its AI services will create enough value to persuade corporate customers to pay more.” “The company is amassing 1.8 million graphics processing units to build and run AI models and related products. It also has a plan to triple data-center capacity, mainly to handle AI workloads. Its capital expenditure hit a record $14 billion in the most recent quarter.” Many investors are concerned that this pharma company isn’t the only company that is finding Microsoft’s Copilot AI services, and those from other companies, not as beneficial as many proclaim. With a big runup in the market capitalizations of the big tech companies over the last 18 months, particularly of the so-called Magnificent 7, those concerns could spark a move in the opposite direction for the share prices of the Magnificent 7.   #technology #innovation #startups #ethics #artificialintelligence https://lnkd.in/gJ_FHBAB

“A pharma company stopped using Microsoft's Copilot AI tool, with an exec citing high cost and low value.” “He compared the slide-generation capability of Microsoft's AI tools to middle school presentations, according to a transcript of a call with the Morgan Stanley analysts that was included in their research note.” “The chief information officer of a pharma company paid extra to have 500 employees use Office 365 Copilot in the fourth quarter of 2023 and first quarter of 2024. This is Microsoft's much-heralded AI upgrade to its popular suite of productivity software.” He paid “about $34 per user a month” for the “E3 version of Microsoft's 365 software suite.” “Adding Copilot AI features costs another $30 per user a month. For 500 employees, that would roughly add an extra $180,000 a year.” “These new Microsoft tools are considered some of the premier examples of powerful artificial intelligence in action in the real world. Investors have bid up Microsoft and other big #tech shares massively, betting that this product and similar offerings will catch on with paying customers.” But the article says: “If a large pharma company can't see $180,000 of value in these tools, that's a problem that should worry the entire tech industry,” a worry that I have written about many times. I have trouble finding any examples of companies claiming productivity improvements from generative text AI, and only a few for generative video AI (marketing videos and helping with movie and TV shows). There was one AI feature that the IT executive found somewhat compelling: that “was the ability to archive and summarize video meetings on Microsoft's Teams app. But he said his legal team was wary of retaining meeting transcripts, so the pharma company didn't use that feature.” Other people have shared their concerns with me about the legal problems from storing their proprietary information like this. Investors are also concerned and thus there are many comments, both internal and external to Microsoft, about “whether its AI services will create enough value to persuade corporate customers to pay more.” “The company is amassing 1.8 million graphics processing units to build and run AI models and related products. It also has a plan to triple data-center capacity, mainly to handle AI workloads. Its capital expenditure hit a record $14 billion in the most recent quarter.” Many investors are concerned that this pharma company isn’t the only company that is finding Microsoft’s Copilot AI services, and those from other companies, not as beneficial as many proclaim. With a big runup in the market capitalizations of the big tech companies over the last 18 months, particularly of the so-called Magnificent 7, those concerns could spark a move in the opposite direction for the share prices of the Magnificent 7.   #technology #innovation #startups #ethics #artificialintelligence https://lnkd.in/gJ_FHBAB

“A pharma company stopped using Microsoft's Copilot AI tool, with an exec citing high cost and low value.” “He compared the slide-generation capability of Microsoft's AI tools to middle school presentations, according to a transcript of a call with the Morgan Stanley analysts that was included in their research note.” “The chief information officer of a pharma company paid extra to have 500 employees use Office 365 Copilot in the fourth quarter of 2023 and first quarter of 2024. This is Microsoft's much-heralded AI upgrade to its popular suite of productivity software.” He paid “about $34 per user a month” for the “E3 version of Microsoft's 365 software suite.” “Adding Copilot AI features costs another $30 per user a month. For 500 employees, that would roughly add an extra $180,000 a year.” “These new Microsoft tools are considered some of the premier examples of powerful artificial intelligence in action in the real world. Investors have bid up Microsoft and other big #tech shares massively, betting that this product and similar offerings will catch on with paying customers.” But the article says: “If a large pharma company can't see $180,000 of value in these tools, that's a problem that should worry the entire tech industry,” a worry that I have written about many times. I have trouble finding any examples of companies claiming productivity improvements from generative text AI, and only a few for generative video AI (marketing videos and helping with movie and TV shows). There was one AI feature that the IT executive found somewhat compelling: that “was the ability to archive and summarize video meetings on Microsoft's Teams app. But he said his legal team was wary of retaining meeting transcripts, so the pharma company didn't use that feature.” Other people have shared their concerns with me about the legal problems from storing their proprietary information like this. Investors are also concerned and thus there are many comments, both internal and external to Microsoft, about “whether its AI services will create enough value to persuade corporate customers to pay more.” “The company is amassing 1.8 million graphics processing units to build and run AI models and related products. It also has a plan to triple data-center capacity, mainly to handle AI workloads. Its capital expenditure hit a record $14 billion in the most recent quarter.” Many investors are concerned that this pharma company isn’t the only company that is finding Microsoft’s Copilot AI services, and those from other companies, not as beneficial as many proclaim. With a big runup in the market capitalizations of the big tech companies over the last 18 months, particularly of the so-called Magnificent 7, those concerns could spark a move in the opposite direction for the share prices of the Magnificent 7.   #technology #innovation #startups #ethics #artificialintelligence https://lnkd.in/gJ_FHBAB